Friday, 15 Feb 2019

Autoimmune/Lupus

Datesort ascending Type Title Save
07 Jan 2019 Social Obesity makes everything worse, including SLE! Study of 148 SLE pts; the 32% who were obese had worse disease activity, depression, pain and fatigue. https://t.co/PQOQrBca2a
07 Jan 2019 ACR Video QD Video - Statins
07 Jan 2019 Social Rheumatology Year in Review - New Drugs, irAEs, Enbrel in court, Opioids, new JAKs, Hot PsA Trial, new Lupus drugs, Medical Marijuana, Expen$ive Rheum drugs, Senolytics. https://t.co/9VpM4yRGfY
02 Jan 2019 Social Eli Lilly has announced that FDA has granted Fast Track designation to baricitinib, to be studied for the treatment of systemic lupus erythematosus (SLE). This drug is NOT FDA approved for lupus https://t.co/vK7i6AoKab
25 Dec 2018 News Best of 2018: Ustekinumab May be Effective in Lupus
24 Dec 2018 Social Bing Bingham MD talking on immune related adverse events (MSK and autoimmune). Says these occur in 3-5% of cancer pts treated with Checkpoint inhibitors. Unofficial surveys show nearly 50% of Rheums have seen these referrals. #MARS #ARTHROS https://t.co/lDLX1qHIDh
19 Dec 2018 News Nailfold Videocapillaroscopy in Dermatomyositis
18 Dec 2018 News TIF1-Ab in Dermatomyositis Linked to Higher Cancer Risk
15 Dec 2018 Social Bing Bingham MD talking on immune related adverse events (MSK and autoimmune). Says these occur in 3-5% of cancer pts treated with Checkpoint inhibitors. Unofficial surveys show nearly 50% of Rheums have seen these referrals. #MARS #ARTHROS https://t.co/yZHMQjpMz8
11 Dec 2018 News Genetic Diagnosis for Previously Undiagnosed Disorders
11 Dec 2018 Social Registry studies of systemic sclerosis shows that early severe GI involvement (9% at 2yrs) is associated with increase risk of inflammatory myositis (OR 4.68), telangiectasias (OR 2.45), skin progression and a >2-fold risk of death (HR 2.27) https://t.co/6e96TldL2S
10 Dec 2018 News SLE and Risk of Malignancy
10 Dec 2018 Social Full text overview of novel biologic and molecular targets studied or in development for SLE. https://t.co/7SGzKNm4Aa https://t.co/ki5toh6O3P
10 Dec 2018 Social Galectin-9 is a biomarker correlating with type 1 IFN signature and correlates w/ disease activity in SLE and and antiphospholipid syndrome and may also correlate with other autoimmune Dz - Sjögren’s, systemic sclerosis & juvenile) dermatomyositis https://t.co/TfpwMAIaaI
06 Dec 2018 News The Benefits of a Lupus Clinic
27 Nov 2018 News Diagnosing Early Lupus from Mimics
27 Nov 2018 Social Musculoskeletal/Rheumatic diseases (arthralgias, myalgias, arthritis, PMR, myositis, Sjogrens, SLE) are uncommon side effects of immune checkpoint inhibitors, so-called irAE (immune related adverse events). Good review here. https://t.co/R52SW0HUjv
26 Nov 2018 News High CV Risk in Lupus
19 Nov 2018 News AURA-LV Trial - Voclosporin Effective in Lupus Nephritis
15 Nov 2018 News Pilot Data on Rituximab in Henoch-Schonlein Purpura